Back to Journals » OncoTargets and Therapy » Volume 6

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation

Total article views   HTML views PDF downloads Totals
10,767 Dovepress* 9,658+ 1,907 11,565
PubMed Central* 1,109 475 1,584
Totals 10,767 2,382 13,149
*Since 1 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 1 0 0 0 2

View citations on PubMed Central and Google Scholar